The FDA approved the first intravenous iron replacement therapy for adults with heart failure.
Injectafer, made by Daiichi Sankyo, is a ferric carboxymaltose injection treatment for iron deficiency in adult patients with heart failure to improve exercise capacity, according to a June 5 company news release. It has already been approved in 86 countries since 2007 and is the most extensively studied IV iron treatment.